inside Pfizer's nine-month race to make the impossible possibleBourla, Albertcreatorauthor.textbibliographyHistory.nyu2022First edition.monographiceng

print

xix, 216 pages, 8 unnumbered pages of plates : illustrations (some color) ; 24 cm"The exclusive, first-hand, behind-the-scenes story of how Pfizer raced to create the first Covid-19 vaccine, told by Pfizer's CEO Dr. Albert Bourla"--"A riveting, fast-paced, inside look at one of the most incredible private sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr. Albert Bourla, made "the impossible possible"--creating, testing, and manufacturing a safe and effective Covid-19 vaccine that previously would have taken years to develop." -- inside front book jacket flap.Preface: Luck never comes to the unprepared -- Business NOT as usual -- What is obvious is not always right -- Thinking big makes the impossible possible -- Lightspeed -- The ultimate joy -- Past, present, future -- Manufacturing, the second miracle -- Equity : easier said than done -- Navigating a political minefield -- A beacon of hope -- The science of trust -- A pro-patient, pro-innovation agenda -- Epilogue -- Acknowledgments -- Appendix: Albert Bourla's "we stand with science" open letter to colleagues.Dr. Albert Bourla.Includes bibliographical references (pages [197]-214).Bourla, AlbertPfizer Inc.Pfizer Inc. fast (OCoLC)fst02024716 Drug developmentHistoryCOVID-19 (Disease)VaccinationViral vaccinesBiotechnologyViral vaccinesVaccines industryImmunologyBiotechnologyCOVID-19 (Disease)PreventionCOVID-19 Pandemic, 2020-COVID-19 vaccinesHistorymRNA vaccinesHistoryViral VaccinesAllergy and ImmunologyBiotechnologyMédicamentsDéveloppementHistoireCOVID-19VaccinationVaccins antivirauxBiotechnologieVaccins antivirauxVaccinsIndustrieImmunologieBiotechnologiePandémie de COVID-19, 2020-bioengineeringBUSINESS & ECONOMICS / Industries / Pharmaceutical & BiotechnologyMEDICAL / ImmunologyBUSINESS & ECONOMICS / Research & DevelopmentBiotechnologyCOVID-19 (Disease)PreventionCOVID-19 (Disease)VaccinationDrug developmentImmunologyVaccines industryViral vaccinesViral vaccinesResearchCOVID-19 (Disease)Bourla, Dr. Albert.New York : Harper Business, 2022(DLC) 2022001764978006321079000632107972022001763Harpercollins, 53 Glenmaura National Blvd Ste 300, Moosaic, PA, USA, 18507-213222030220220525103634.01266258710